April 2 (Bloomberg) -- Steve Miller, chief medical officer at Express Scripts Inc., talks about the company’s $29.1 billion bid for rival drug benefit manager Medco Health Solutions Inc. The offer won unconditional approval from U.S. antitrust regulators, clearing the way for the creation of the biggest manager of prescription-drug benefits for corporate and government clients. Miller speaks on Bloomberg Television’s “InBusiness With Margaret Brennan.” (Source: Bloomberg)Read Full Story
Financial TimesExpress Scripts to Buy Medco Health for $29.1 BillionWall Street JournalExpress Scripts Inc.'s agreement to buy Medco Health Solutions Inc. for $29.1 billion in cash and stock links together two of the nation's largest pharmacy-benefit managers at a time one of them faces losing its biggest customer. ...Medco Deal Fuels Health Care's Hot StreakTheStreet.comHow Generics And ObamaCare Led To Express Scripts' Mammoth Purchase Of MedcoForbes (blog)Express Scripts 2nd-quarter profit...Read Full Story
(Reuters) - Express Scripts Inc <ESRX.O> has agreed to buy rival Medco Health Solutions Inc <MHS.N> for about $29 billion, combining two of the largest U.S. pharmacy-benefit managers, the Wall Street Journal reported, citing sources.Express Scripts was expected to pay $71.36 per share in cash and stock for Medco, the newspaper said on Thursday.Medco shares closed at $55.78 on Wednesday.The deal was signed early Thursday morning and could be announced on Thursday, the Journal said.An Express Scripts...Read Full Story
Financial TimesExpress Scripts to buy Medco for $29 billionLos Angeles TimesExpress Scripts Inc. announced an agreement Thursday to buy Medco Health Solutions Inc., which is bigger in terms of revenue, but recently lost several major contracts covering millions of people. Combined, Express Scripts and Medco would handle ...Express Scripts to Buy Medco Health for $29.1 BillionWall Street JournalHow Generics And ObamaCare Led To Express Scripts' Mammoth Purchase Of MedcoForbes (blog)Medco Deal...Read Full Story
New York TimesExpress Scripts to Buy Medco in $29.1 Billion Bid to Gain ScaleBusinessWeekJuly 21 (Bloomberg) -- Express Scripts Inc. agreed to buy Medco Health Solutions Inc. for $29.1 billion in the largest deal in at least a decade among US companies that manage prescription-drug benefits. The $71.36-a-share offer in cash ...Express Scripts, Medco Deal Comes As PBM Industry EvolvesWall Street JournalExpress Scripts, Medco Bankers May Reap $120 Million in M&A Advisory FeesBloombergExpress...Read Full Story
A judge in Pittsburgh on Wednesday denied an injunction by the National Association of Chain Drug Stores, the National Community Pharmacists Association and independent pharmacies to undo the $29.1 billion merger of Express Scripts Inc. and Medco Health Solutions Inc..
St. Louis Business Journal reports U.S. District Judge Cathy Bissoon denied the motion, stating the pharmacy groups did not provide sufficient evidence to temporary halt the...
A federal judge heard three hours of arguments Tuesday in a lawsuit filed March 29 by pharmacy trade groups to halt Express Scripts' $29.1 billion acquisition of New Jersey-based Medco Health Solutions, Bloomberg Businessweek reports.
St. Louis-based Express Scripts (NYSE: ESRX) completed the deal April 2 after receiving FTC approval and has asked that the lawsuit be dismissed. But the plaintiffs, including the National Association of Chain...
Express Scripts closed on its $29.1 billion acquisition of Medco Health Solutions Monday, St. Louis Business Journal reports.
The deal creates the largest pharmacy benefits manager in the U.S., with about $100 billion in annual revenue. It also brings about 1,800 local employees under the Express Scripts umbrella: Medco's specialty pharmacy group, Accredo Health Group Inc., is based in Memphis.
First announced in July 2011, the acquisition...
The Federal Trade Commission voted 3-1 Monday to close its investigation of the proposed acquisition of pharmacy benefits manager Medco Health Solutions Inc. by Express Scripts Inc., paving the way for the pharmaceutical benefit managements to complete the $29 billion deal.
By closing its investigation, the majority of the FTC board found the sale will not reduce competition for the provision of pharmacy benefit management services within the...
VANCOUVER, British Columbia, March 29, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Microsoft (NASDAQ:MSFT), Medco Health Solutions (NYSE:MHS), Tyco International (NYSE:TYC), Baker Hughes (NYSE:BHI),...
CEO David Snow has been the chief executive officer of Medco Health Solutions since 2003. He is 51 years old. Follow Mr. Snow and Medco Health Solutions in the news and blogs or share your own opinion about the company and its leadership.